Weight-loss drugs now linked to cancer protection in women, major new study reveals
A new study finds that GLP-1 medications are linked to lower overall cancer risk, particularly for endometrial and ovarian cancers, in obese adults. Oncologist Dr. Slomovitz discusses the findings.
A new study finds that GLP-1 medications are linked to lower overall cancer risk, particularly for endometrial and ovarian cancers, in obese adults. Oncologist Dr. Slomovitz discusses the findings.
Read the full article at:
Fox News →